These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1306 related articles for article (PubMed ID: 17048973)

  • 61. The Effects of Obesity on Drug Metabolism in Children.
    Oeser SG; Rougee LR; Collier AC
    Drug Metab Lett; 2015; 9(2):88-98. PubMed ID: 26411468
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Physiologically based predictions of the impact of inhibition of intestinal and hepatic metabolism on human pharmacokinetics of CYP3A substrates.
    Fenneteau F; Poulin P; Nekka F
    J Pharm Sci; 2010 Jan; 99(1):486-514. PubMed ID: 19479982
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Population pharmacokinetics of doxorubicin: establishment of a NONMEM model for adults and children older than 3 years.
    Kontny NE; Würthwein G; Joachim B; Boddy AV; Krischke M; Fuhr U; Thompson PA; Jörger M; Schellens JH; Hempel G
    Cancer Chemother Pharmacol; 2013 Mar; 71(3):749-63. PubMed ID: 23314734
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Specific features of pharmacokinetics in children.
    Matalová P; Urbánek K; Anzenbacher P
    Drug Metab Rev; 2016; 48(1):70-9. PubMed ID: 26828377
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Mechanistic basis of using body size and maturation to predict clearance in humans.
    Anderson BJ; Holford NH
    Drug Metab Pharmacokinet; 2009; 24(1):25-36. PubMed ID: 19252334
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Practical treatment guide for dose individualisation in cancer chemotherapy.
    Canal P; Chatelut E; Guichard S
    Drugs; 1998 Dec; 56(6):1019-38. PubMed ID: 9878990
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Population pharmacokinetics of tacrolimus in pediatric liver transplantation: early posttransplantation clearance.
    Wallin JE; Bergstrand M; Wilczek HE; Nydert PS; Karlsson MO; Staatz CE
    Ther Drug Monit; 2011 Dec; 33(6):663-72. PubMed ID: 22105583
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Clinical pharmacokinetics of changes in drug elimination in children.
    Prandota J
    Dev Pharmacol Ther; 1985; 8(5):311-28. PubMed ID: 3899553
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Pitfalls of pharmacokinetic dosage guidelines in renal insufficiency.
    Turnheim K
    Eur J Clin Pharmacol; 1991; 40(1):87-93. PubMed ID: 2060552
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Using pharmacokinetics to predict the effects of pregnancy and maternal-infant transfer of drugs during lactation.
    Anderson GD
    Expert Opin Drug Metab Toxicol; 2006 Dec; 2(6):947-60. PubMed ID: 17125410
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Clincial pharmacokinetics in neonates.
    Morselli PL
    Clin Pharmacokinet; 1976; 1(2):81-98. PubMed ID: 13955
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Ethnic or racial differences revisited: impact of dosage regimen and dosage form on pharmacokinetics and pharmacodynamics.
    Chen ML
    Clin Pharmacokinet; 2006; 45(10):957-64. PubMed ID: 16984210
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Dosage Adjustments Related to Young or Old Age and Organ Impairment.
    Burris JF; Tortorici MA; Mandic M; Neely M; Reed MD
    J Clin Pharmacol; 2016 Dec; 56(12):1461-1473. PubMed ID: 27539787
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Pharmacokinetics in Children - What is Important for Correct Drug Dosage?].
    Fideler F
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2019 Jul; 54(7-08):496-506. PubMed ID: 31344745
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Dosing in children: a critical review of the pharmacokinetic allometric scaling and modelling approaches in paediatric drug development and clinical settings.
    Mahmood I
    Clin Pharmacokinet; 2014 Apr; 53(4):327-46. PubMed ID: 24515100
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Age differences in trimethoprim pharmacokinetics: need for revised dosing in children?
    Hoppu K
    Clin Pharmacol Ther; 1987 Mar; 41(3):336-43. PubMed ID: 3816021
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Pharmacokinetics and dosage adjustment in patients with hepatic dysfunction.
    Verbeeck RK
    Eur J Clin Pharmacol; 2008 Dec; 64(12):1147-61. PubMed ID: 18762933
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Size, myths and the clinical pharmacokinetics of analgesia in paediatric patients.
    Anderson BJ; McKee AD; Holford NH
    Clin Pharmacokinet; 1997 Nov; 33(5):313-27. PubMed ID: 9391745
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Development and applications of a physiologically-based model of paediatric oral drug absorption.
    Johnson TN; Bonner JJ; Tucker GT; Turner DB; Jamei M
    Eur J Pharm Sci; 2018 Mar; 115():57-67. PubMed ID: 29309876
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Estimating pediatric doses of drugs metabolized by cytochrome P450 (CYP) isozymes, based on physiological liver development and serum protein levels.
    Suzuki S; Murayama Y; Sugiyama E; Hirunpanich V; Saito K; Sekiyama M; Sato H
    Yakugaku Zasshi; 2010 Apr; 130(4):613-20. PubMed ID: 20372009
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 66.